Live Attenuated Measles Virus Vaccine Expressing

Helicobacter pylori heat-shock protein A immune check point immune response measles virus oncolytic agent vaccine

Journal

Molecular therapy oncolytics
ISSN: 2372-7705
Titre abrégé: Mol Ther Oncolytics
Pays: United States
ID NLM: 101666776

Informations de publication

Date de publication:
16 Dec 2020
Historique:
received: 06 05 2020
accepted: 17 09 2020
entrez: 4 11 2020
pubmed: 5 11 2020
medline: 5 11 2020
Statut: epublish

Résumé

Measles virus (MV) Edmonston derivative strains are attractive vector platforms in vaccine development and oncolytic virotherapy.

Identifiants

pubmed: 33145397
doi: 10.1016/j.omto.2020.09.006
pii: S2372-7705(20)30145-5
pmc: PMC7585873
doi:

Types de publication

Journal Article

Langues

eng

Pagination

136-148

Subventions

Organisme : NCI NIH HHS
ID : R01 CA200507
Pays : United States
Organisme : NHLBI NIH HHS
ID : T32 HL007974
Pays : United States

Informations de copyright

© 2020 The Author(s).

Références

Annu Rev Immunol. 2001;19:523-63
pubmed: 11244046
Blood. 2004 Mar 1;103(5):1641-6
pubmed: 14604966
Clin Vaccine Immunol. 2008 Jul;15(7):1054-9
pubmed: 18463223
Infect Immun. 1997 Feb;65(2):699-707
pubmed: 9009333
World J Clin Cases. 2016 Jan 16;4(1):5-19
pubmed: 26798626
J Immunol. 2015 Apr 15;194(8):3997-4007
pubmed: 25769921
MMWR Morb Mortal Wkly Rep. 2019 Dec 06;68(48):1105-1111
pubmed: 31805033
Vaccine. 2007 Apr 20;25(16):2974-83
pubmed: 17303293
Mol Biol Rep. 2011 Jun;38(5):3173-80
pubmed: 20127514
Cancer Gene Ther. 2014 Nov;21(11):483-90
pubmed: 25394505
Clin Vaccine Immunol. 2017 Jan 5;24(1):
pubmed: 27535837
Gastroenterology. 2009 May;136(6):1863-73
pubmed: 19457415
J Immunol. 2014 Aug 1;193(3):1233-45
pubmed: 24990079
Virus Res. 2019 Apr 2;263:145-150
pubmed: 30684519
EMBO J. 1995 Dec 1;14(23):5773-84
pubmed: 8846771
Gene Ther. 2019 May;26(5):151-164
pubmed: 30718755
J Intern Med. 2009 Apr;265(4):421-38
pubmed: 19298458
Vaccine. 2013 Oct 1;31(42):4795-801
pubmed: 23948230
J Biol Chem. 2008 May 30;283(22):15142-51
pubmed: 18364351
Microbes Infect. 2003 Jul;5(8):705-13
pubmed: 12814771
J Infect Dis. 2009 Oct 15;200(8):1311-7
pubmed: 19751153
J Biol Inorg Chem. 2007 Aug;12(6):831-42
pubmed: 17503094
Microb Pathog. 2009 Oct;47(4):231-6
pubmed: 19683049
Sci Rep. 2016 Nov 21;6:37367
pubmed: 27869178
J Virol. 1999 Nov;73(11):9568-75
pubmed: 10516065
Mol Ther. 2009 Aug;17(8):1395-403
pubmed: 19471250
Helicobacter. 2008 Jun;13(3):191-9
pubmed: 18466394
Mol Ther. 2012 Jun;20(6):1139-47
pubmed: 22334023
Curr Microbiol. 2011 Sep;63(3):239-49
pubmed: 21735226
J Cell Physiol. 2008 Jul;216(1):78-82
pubmed: 18205181
J Immunol. 2018 Jul 1;201(1):264-277
pubmed: 29752314
J Virol. 1998 Feb;72(2):891-9
pubmed: 9444980
J Virol. 1998 Sep;72(9):7420-7
pubmed: 9696838
Expert Opin Biol Ther. 2013 Apr;13(4):483-502
pubmed: 23289598
Clin Microbiol Rev. 2006 Jul;19(3):449-90
pubmed: 16847081
Mol Ther. 2007 Mar;15(3):588-97
pubmed: 17245355
Expert Opin Biol Ther. 2017 Mar;17(3):353-363
pubmed: 28129716
J Microbiol. 2010 Apr;48(2):223-8
pubmed: 20437155
J Natl Cancer Inst. 2018 Oct 1;110(10):1123-1132
pubmed: 29788332
Mol Ther. 2007 Jan;15(1):114-22
pubmed: 17164782
Expert Rev Vaccines. 2019 Apr;18(4):393-403
pubmed: 30601074
PLoS One. 2015 Jun 23;10(6):e0130391
pubmed: 26102080
Vaccine. 2011 Feb 11;29(8):1710-20
pubmed: 21182995
Cancer Res. 2015 Jan 1;75(1):22-30
pubmed: 25398436
Sci Rep. 2017 Dec 4;7(1):16892
pubmed: 29203786
J Virol. 2007 Dec;81(23):12859-71
pubmed: 17898060
Vaccine. 2009 Feb 5;27(6):846-52
pubmed: 19084566
Virology. 2007 Mar 30;360(1):72-83
pubmed: 17112561
Prostate. 2009 Jan 1;69(1):82-91
pubmed: 18973133
Curr Cancer Drug Targets. 2018;18(2):177-187
pubmed: 28228086
J Biol Chem. 2019 Feb 8;294(6):2109-2120
pubmed: 30401745
Breast Cancer Res Treat. 2010 Aug;122(3):745-54
pubmed: 19894113
Infect Genet Evol. 2017 Apr;49:309-317
pubmed: 28185986
J Virol. 2019 Jan 17;93(3):
pubmed: 30429338
Microbiology (Reading). 1997 Jan;143 ( Pt 1):45-53
pubmed: 9025277
Oncoimmunology. 2017 Jan 31;6(4):e1285992
pubmed: 28507792
Nat Rev Cancer. 2019 Mar;19(3):133-150
pubmed: 30755690
Mol Ther Oncolytics. 2018 Dec 31;12:147-161
pubmed: 30775418
Cancer Gene Ther. 2013 Nov;20(11):630-7
pubmed: 24157925
Stem Cell Res Ther. 2015 Mar 26;6:48
pubmed: 25889591
J Bacteriol. 2010 Mar;192(5):1231-7
pubmed: 20061471

Auteurs

Ianko D Iankov (ID)

Department of Molecular Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
Division of Medical Oncology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.

Cheyne Kurokawa (C)

Department of Molecular Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.

Kimberly Viker (K)

Department of Molecular Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.

Steven I Robinson (SI)

Department of Molecular Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
Division of Medical Oncology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.

Arun Ammayappan (A)

Department of Molecular Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.

Eleni Panagioti (E)

Department of Molecular Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.

Mark J Federspiel (MJ)

Department of Molecular Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.

Evanthia Galanis (E)

Department of Molecular Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
Division of Medical Oncology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.

Classifications MeSH